Stay updated on MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays release version v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T02:09:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical-trial record is displayed instead of an error page, with details about the pembrolizumab-plus-docetaxel versus docetaxel study, its participants and design, and its results. The record also includes study documents and information about sharing participant data.
    Difference
    56%
    Check dated 2026-11-11T01:17:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record is now displayed for the completed phase II study comparing pembrolizumab (MK-3475) plus docetaxel with docetaxel alone in previously treated non-small cell lung cancer. It includes study details, outcome measures, participant criteria, and results-related information.
    Difference
    56%
    Check dated 2026-11-03T23:30:43.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A general NIH notice about changes in terminology appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:20:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:07.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, signaling a site version update. A substantial set of older study documents and related entries were removed from the listing.
    Difference
    19%
    Check dated 2026-09-23T00:32:05.000Z thumbnail image

Stay in the know with updates to MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page.